Human resource development contributes to the creation of outstanding regenerative medicine products

被引：5

作者：

Nishigaki, Fusako ^{[1
,2
]}

Ezoe, Sachikon ^{[3
]}

Kitajima, Hideki ^{[3
]}

Hata, Kenichiro ^{[2
,4
]}

机构：

[1] Astellas Pharma Inc, Regenerat Med Labs, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan

[2] FIRM, Chuo Ku, 2-3-11 Nihonbashi Honcho, Tokyo 1030023, Japan

[3] Osaka Univ Hosp, Dept Med Innovat, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan

[4] Japan Tissue Engn Co Ltd J TEC, Gamagori, Aichi, Japan

来源：

REGENERATIVE THERAPY | 2017年 / 7卷

关键词：

Regenerative medicine; Human resource; Education; Training; JAPAN; GENE;

D O I：

10.1016/j.reth.2017.06.002

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

Regenerative medicine is currently the focus of global attention. Countries all around the world are actively working to create new regenerative treatment modalities through pioneering research and novel technologies. This is wonderful news for patients who could not be treated with existing medical options. New venture businesses and companies are being established in regenerative medicine and their rapid industrialization is anticipated. However, to ensure high-quality products, human resources qualified in research and development and the manufacturing of these products are essential. The Forum for Innovative Regenerative Medicine (FIRM) conducted a questionnaire of its industry members to examine the training and hiring of people in research and development, product creation, manufacturing, and more. Regenerative medicine is a brand new field; thus, many different businesses will need to cooperate together. People with a broad range of technical skills, abilities, and knowledge will be in demand, with various levels of expertise, from basic to advanced. (C) 2017, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.

引用

页码：17 / 23

页数：7

共 50 条

[31] Regenerative Medicine: Potential of resource oriented treatment for old-age diseases
Tiedemann, G.
Wagner, A.
BEWEGUNGSTHERAPIE UND GESUNDHEITSSPORT, 2011, 27 (02): : 70 - 73
[32] The early career researcher's toolkit: translating tissue engineering, regenerative medicine and cell therapy products
Rafiq, Qasim A.
Ortega, Ilida
Jenkins, Stuart I.
Wilson, Samantha L.
Patel, Asha K.
Barnes, Amanda L.
Adams, Christopher F.
Delcassian, Derfogail
Smith, David
REGENERATIVE MEDICINE, 2015, 10 (08) : 989 - 1003
[33] THE APPROVAL OF ORGANOID BASED REGENERATIVE MEDICINE FOR THE FIRST IN HUMAN TRIAL IN REPUBLIC OF KOREA: DEVELOPMENT STRATEGY AND CONSIDERATION
Lee, K.
Park, J.
CYTOTHERAPY, 2023, 25 (06) : S151 - S152
[34] Employment of the Triple Helix concept for development of regenerative medicine applications based on human pluripotent stem cells
Sartipy, Peter
Bjoerquist, Petter
CLINICAL AND TRANSLATIONAL MEDICINE, 2014, 3
[35] Development of the hyperspectral cellular imaging system to apply to regenerative medicine
Ishihara, Miya
Sato, Masato
Matsumura, Kouji
Mochida, Joji
Kikuchi, Makoto
OPTICS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE IV, 2010, 7566
[36] The emerging landscape of reimbursement of regenerative medicine products in the UK: publications, policies and politics
Mahalatchimy, Aurelie
Faulkner, Alex
REGENERATIVE MEDICINE, 2017, 12 (06) : 611 - 622
[37] The Social Life of "Scaffolds": Examining Human Rights in Regenerative Medicine
Parry, Bronwyn
SCIENCE TECHNOLOGY & HUMAN VALUES, 2018, 43 (01) : 95 - 120
[38] Editorial: Functional and Smart Biomaterials: Development and Application in Regenerative Medicine
Li, Guicai
Zhang, Hongbo
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
[39] Human Resource Development ≠ Human Resource Management: So What Is It?
Werner, Jon M.
HUMAN RESOURCE DEVELOPMENT QUARTERLY, 2014, 25 (02) : 127 - 139
[40] The long path of human placenta, and its derivatives, in regenerative medicine
Silini, Antonietta R.
Cargnoni, Anna
Magatti, Marta
Pianta, Stefano
Parolini, Ornella
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2015, 3

← 1 2 3 4 5 →